ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,224Medicare Part D Prescriptions Filled, Including Refills
$1.02M Total Retail Price of All Prescriptions
591 Patients Receiving at Least One Drug in Part D
11%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
RISPERIDONE 587 32
TRAZODONE HCL 573 45
CITALOPRAM HBR 573 82
LAMOTRIGINE 376 27
FLUOXETINE HCL 363 17
GABAPENTIN 358 36
CYMBALTA 349 59
MIRTAZAPINE 338 89
SERTRALINE HCL 321 59
ABILIFY 321 21
BENZTROPINE MESYLATE 269 31 R
BUSPIRONE HCL 261 35
QUETIAPINE FUMARATE 259 26
TOPIRAMATE 225 0
OLANZAPINE 197 19
HYDROXYZINE PAMOATE 189 21 R
DIVALPROEX SODIUM 187 15
VENLAFAXINE HCL ER 183 30
BUPROPION HCL SR 166 0
BUPROPION HCL 165 0
LITHIUM CARBONATE 165 0
CARBAMAZEPINE 163 0
PAROXETINE HCL 158 29
ZIPRASIDONE HCL 146 36
OXCARBAZEPINE 131 0
CLOZAPINE 127 0
PRAZOSIN HCL 120 0
VENLAFAXINE HCL 111 15
AMITRIPTYLINE HCL 102 0 R
HALOPERIDOL 94 0
ZOLPIDEM TARTRATE 94 19
INVEGA 93 14
ESCITALOPRAM OXALATE 92 19
SEROQUEL 87 14
DOXEPIN HCL 86 0
DONEPEZIL HCL 68 41
CLONIDINE HCL 61 0
PROPRANOLOL HCL 60 0
SEROQUEL XR 58 0
DIVALPROEX SODIUM ER 52 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.